Elutia Inc. (ELUT)
Largest Insider Buys in Sector
ELUT Stock Price History Chart
ELUT Stock Performance
About Elutia Inc.
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection …
Insider Activity of Elutia Inc.
Over the last 12 months, insiders at Elutia Inc. have bought $0 and sold $0 worth of Elutia Inc. stock.
On average, over the past 5 years, insiders at Elutia Inc. have bought $2.13M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $15,870 was made by Birchview Capital, LP (10% owner in previous filing) on 2023‑03‑27.
List of Insider Buy and Sell Transactions, Elutia Inc.
| 2023-03-27 | 10% owner in previous filing | 10,000 0.0111% | $1.59 | $15,870 | +17.78% | |||
| 2023-03-24 | 10% owner in previous filing | 20,000 0.0189% | $1.35 | $27,078 | +42.18% | |||
| 2023-03-23 | 10% owner in previous filing | 110,000 0.1146% | $1.49 | $164,010 | +48.57% | |||
| 2021-09-21 | 2.84M 2.8304% | $1.43 | $4.05M | -16.71% |
Insider Historical Profitability
| HighCape Capital, L.P. | 8434732 24.4046% | $4.32 | 1 | 0 | <0.0001% | |
| Birchview Capital, LP | 10% owner in previous filing | 1655184 4.789% | $4.32 | 3 | 0 | +36.18% |